Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre-Alain Burnouf

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Advanced Drug Delivery Reviews|February 25, 2019
Nanoformulation properties, characterization, and behavior in complex biological matrices: Challenges and opportunities for brain-targeted drug delivery applications and enhanced translational potentialVibhuti Agrahari, Pierre-Alain Burnouf, Thierry Burnouf, et al.
ACS Applied Bio Materials|July 8, 2025
Safe and Efficient Intracellular Release of SN38 via Lysosomal-Responsive SN38-G Loaded LiposomesPierre-Alain Burnouf, Yu-Cheng Su, Shih-Hung Yang
Journal of Separation Science|December 17, 2013
Versatile online SPE-HPLC method for the analysis of Irinotecan and its clinically relevant metabolites in biomaterialsZeljko M Prijovich, Pierre-Alain Burnouf, Steve R Roffler
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 30, 2022
Glucuronides: From biological waste to bio-nanomedical applicationsPierre-Alain Burnouf, Steve R Roffler, Chia-Ching Wu, et al.
Trends in Biotechnology|January 15, 2019
Extracellular Microvesicles as New Industrial Therapeutic FrontiersVivek Agrahari, Vibhuti Agrahari, Pierre-Alain Burnouf, et al.
Drug Discovery Today|September 18, 2017
Circulatory-cell-mediated nanotherapeutic approaches in disease targetingThierry Burnouf, Pierre-Alain Burnouf, Yu-Wen Wu, et al.
Nature Communications|May 12, 2018
Reversible glycosidic switch for secure delivery of molecular nanocargosPierre-Alain Burnouf, Yu-Lin Leu, Yu-Cheng Su, et al.
Nature Communications|June 9, 2017
Conditional internalization of PEGylated nanomedicines by PEG engagers for triple negative breast cancer therapyYu-Cheng Su, Pierre-Alain Burnouf, Kuo-Hsiang Chuang, et al.
Platelets|November 30, 2020
Human platelet lysates for human cell propagationLassina Barro, Pierre-Alain Burnouf, Ming-Li Chou, et al.
Molecular Pharmaceutics|January 30, 2016
Synthesis and Antitumor Properties of BQC-Glucuronide, a Camptothecin Prodrug for Selective Tumor ActivationZeljko M Prijovich, Pierre-Alain Burnouf, Hua-Cheng Chou, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Advanced Drug Delivery Reviews|February 25, 2019
Nanoformulation properties, characterization, and behavior in complex biological matrices: Challenges and opportunities for brain-targeted drug delivery applications and enhanced translational potentialVibhuti Agrahari, Pierre-Alain Burnouf, Thierry Burnouf, et al.
ACS Applied Bio Materials|July 8, 2025
Safe and Efficient Intracellular Release of SN38 via Lysosomal-Responsive SN38-G Loaded LiposomesPierre-Alain Burnouf, Yu-Cheng Su, Shih-Hung Yang
Journal of Separation Science|December 17, 2013
Versatile online SPE-HPLC method for the analysis of Irinotecan and its clinically relevant metabolites in biomaterialsZeljko M Prijovich, Pierre-Alain Burnouf, Steve R Roffler
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 30, 2022
Glucuronides: From biological waste to bio-nanomedical applicationsPierre-Alain Burnouf, Steve R Roffler, Chia-Ching Wu, et al.
Trends in Biotechnology|January 15, 2019
Extracellular Microvesicles as New Industrial Therapeutic FrontiersVivek Agrahari, Vibhuti Agrahari, Pierre-Alain Burnouf, et al.
Drug Discovery Today|September 18, 2017
Circulatory-cell-mediated nanotherapeutic approaches in disease targetingThierry Burnouf, Pierre-Alain Burnouf, Yu-Wen Wu, et al.
Nature Communications|May 12, 2018
Reversible glycosidic switch for secure delivery of molecular nanocargosPierre-Alain Burnouf, Yu-Lin Leu, Yu-Cheng Su, et al.
Nature Communications|June 9, 2017
Conditional internalization of PEGylated nanomedicines by PEG engagers for triple negative breast cancer therapyYu-Cheng Su, Pierre-Alain Burnouf, Kuo-Hsiang Chuang, et al.
Platelets|November 30, 2020
Human platelet lysates for human cell propagationLassina Barro, Pierre-Alain Burnouf, Ming-Li Chou, et al.
Molecular Pharmaceutics|January 30, 2016
Synthesis and Antitumor Properties of BQC-Glucuronide, a Camptothecin Prodrug for Selective Tumor ActivationZeljko M Prijovich, Pierre-Alain Burnouf, Hua-Cheng Chou, et al.
Pageof 2